NeuroMetrix Inc (NURO)

2.75
0.04 1.40
NASDAQ : Health Care
Prev Close 2.79
Open 2.89
Day Low/High 2.75 / 2.89
52 Wk Low/High 1.35 / 4.96
Volume 5.06K
Avg Volume 138.70K
Exchange NASDAQ
Shares Outstanding 1.27M
Market Cap 3.45M
EPS -58.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.

NeuroMetrix To Present At The Marcum Microcap Conference On June 16, 2017

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N.

NeuroMetrix Exhibits Quell Wearable Technology At 31st Annual SLEEP Meeting

NeuroMetrix, Inc. (Nasdaq: NURO) is showing  Quell®, its 100% drug-free Wearable Pain Relief Technology™ to sleep medicine professionals from around the world at SLEEP 2017, the 31st Annual...

NeuroMetrix To Present At The LD Micro Invitational Conference On June 6, 2017

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N.

NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.

NeuroMetrix Wins SBANE New England Innovation Award

NeuroMetrix, Inc. (Nasdaq:NURO) announced that it was the recipient of the Smaller Businesses Association of New England (SBANE) New England Innovation Award for the development and successful launch of Quell ®...

NeuroMetrix Launches The LivingQuell Blog, A New Platform For Exploring Perspectives On Chronic Pain

NeuroMetrix, Inc. (Nasdaq: NURO) today announced the launch of LivingQuell, a blog that will serve as an online resource for people affected by chronic pain - as well as the rapidly growing user base of the company's...

Preliminary Results From Clinical Study Evaluating Use Of Quell In Chemotherapy-Induced Peripheral Neuropathy To Be Presented At The American Pain Society Annual Meeting

NeuroMetrix, Inc. (Nasdaq: NURO) today reported that researchers from the University of Rochester School of Medicine and Dentistry will present a scientific poster titled "Wearable TENs band for chemotherapy-induced...

NeuroMetrix Announces One-for-Eight Reverse Split

NeuroMetrix, Inc. (NASDAQ:NURO) today announced a one-for-eight reverse split of its common stock effective as of Thursday, May 11, 2017.

NeuroMetrix Reports Substantial Expansion Of International Intellectual Property Assets For Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq: NURO) reported today that Notices of Allowance has been issued for patents covering key technological features of the Company's Quell ® Wearable Pain Relief Technology™ by the European...

NeuroMetrix Hosts Inaugural Quell User Event

NeuroMetrix, Inc. (Nasdaq: NURO) held its first Quell ® Wearable Pain Relief Technology™ user event last Thursday, April 27.

NeuroMetrix Reports Q1 2017 Financial Results

NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended March 31, 2017.

NeuroMetrix Announces Availability Of Quell Wearable Pain Relief Technology At Bed Bath & Beyond

NeuroMetrix, Inc. (Nasdaq: NURO) today announced the availability of its flagship product, Quell®, at select number of Bed Bath & Beyond ® locations in North America.

NeuroMetrix Named A 50+ Innovation Leader

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it was selected as one of the healthcare industry's 50+ Innovation Leaders under an AARP initiative administered by MedCity News to recognize entrepreneurs, companies,...

NeuroMetrix, Inc. Announces Date For 2017 First Quarter Financial Results Conference Call

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2017 first quarter financial results before the opening of the market on Thursday, April 20, 2017.

NeuroMetrix Brings Quell Wearable For Pain Relief To American Academy Of Pain Medicine 33rd Annual Meeting

Coming together with thousands of leading clinicians who treat patients with chronic pain, NeuroMetrix, Inc.

NeuroMetrix Announces Availability Of Quell Wearable Pain Relief Technology At Best Buy

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell ® will be available in over 450 Best Buy ® stores nationwide beginning in mid-February and is now available for purchase on BestBuy.

NeuroMetrix Reports Q4 And Full Year 2016 Financial Results

NeuroMetrix Reports Q4 And Full Year 2016 Financial Results

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW), today reported financial and business highlights for the quarter and year ended December 31, 2016.

NeuroMetrix, Inc. Announces Date For 2016 Full Year And Fourth Quarter Financial Results Conference Call

NeuroMetrix, Inc. Announces Date For 2016 Full Year And Fourth Quarter Financial Results Conference Call

NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it plans to issue its 2016 full year and fourth quarter financial results before the opening of the market on January 26, 2017.

NeuroMetrix Reports Strong Quell Demand In Q4 2016

NeuroMetrix Reports Strong Quell Demand In Q4 2016

NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO, NUROW) reported Q4 2016 demand highlights for its Quell ® Wearable Pain Relief Technology™.

NeuroMetrix To Present At The Digital Medicine Showcase 2017: At The Intersection Of Technology And Medicine

NeuroMetrix To Present At The Digital Medicine Showcase 2017: At The Intersection Of Technology And Medicine

NeuroMetrix, Inc. (NASDAQ:NURO, NUROW) today announced that Shai N.

NeuroMetrix Closes $7.0 Million Private Placement Of Preferred Stock And Warrants

NeuroMetrix Closes $7.0 Million Private Placement Of Preferred Stock And Warrants

NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced that it has closed its previously announced private placement to a healthcare dedicated institutional investor of 7,000 shares of Series E convertible preferred stock at a...

NeuroMetrix To Present At Biotech Showcase 2017

NeuroMetrix To Present At Biotech Showcase 2017

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Shai N.

CES 2017: NeuroMetrix Brings Life-Enhancing Technology To Those Suffering From Chronic Pain

CES 2017: NeuroMetrix Brings Life-Enhancing Technology To Those Suffering From Chronic Pain

NeuroMetrix, Inc. (Nasdaq:NURO, NUROW) today announced plans to unveil important advances to its Quell® Wearable Pain Relief Technology™ at CES 2017 (CES Unveiled, Table 128 and CES Tech West booth #43421) in...

NeuroMetrix Announces $7.0 Million Private Placement Of Preferred Stock And Warrants

NeuroMetrix Announces $7.0 Million Private Placement Of Preferred Stock And Warrants

NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it has entered into a definitive securities purchase agreement with a healthcare dedicated institutional investor in connection with a private placement of...

NeuroMetrix Announces Participation In CES 2017

NeuroMetrix Announces Participation In CES 2017

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) Building on sales to over 50,000 chronic pain sufferers who have tried Quell ® since its launch in June 2015, NeuroMetrix announced today that it will unveil innovative...

NeuroMetrix Announces $26.5 Million Public Offering

NeuroMetrix Announces $26.5 Million Public Offering

NeuroMetrix, Inc. ("NeuroMetrix" or the "Company") (NASDAQ: NURO, NUROW) announced today the pricing of a public offering with expected gross proceeds from the offering of $26.

NeuroMetrix Reports Expanded Media Coverage For Quell Wearable Pain Relief

NeuroMetrix Reports Expanded Media Coverage For Quell Wearable Pain Relief

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported increased media attention on the company's Quell ® Wearable Pain Relief Technology ™, including an in depth report on CBS's Innovation Nation.